Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies2
  • 7D7.5%
  • 3M45.2%
  • 1Y141.9%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.1%, driven by ChemoMetec declining 4.2%. In contrast, Gubra has gained 6.1%. Over the past 12 months, the industry was up 117%. As for the next few years, earnings are expected to grow by 18% per annum.

Industry Valuation and Performance

Has the Danish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 01 Feb 2025DKK 20.5bDKK 631.7mDKK 89.8m71.5x228.9x32.5x
Mon, 30 Dec 2024DKK 19.1bDKK 631.7mDKK 89.8m64.9x213x30.3x
Wed, 27 Nov 2024DKK 18.8bDKK 631.7mDKK 89.8m61.4x209.5x29.8x
Fri, 25 Oct 2024DKK 14.1bDKK 631.7mDKK 89.8m53.2x156.7x22.3x
Sun, 22 Sep 2024DKK 15.7bDKK 631.7mDKK 89.8m54.9x175.3x24.9x
Tue, 20 Aug 2024DKK 16.8bDKK 606.5mDKK 99.3m47x169.2x27.7x
Thu, 18 Jul 2024DKK 16.9bDKK 606.5mDKK 99.3m47.1x169.9x27.8x
Sat, 15 Jun 2024DKK 10.9bDKK 606.5mDKK 99.3m38.1x109.4x17.9x
Mon, 13 May 2024DKK 10.9bDKK 606.5mDKK 99.3m37.9x110.3x18.1x
Wed, 10 Apr 2024DKK 11.1bDKK 606.5mDKK 99.3m44x111.5x18.3x
Fri, 08 Mar 2024DKK 13.3bDKK 606.5mDKK 99.3m64.1x133.9x21.9x
Sun, 04 Feb 2024DKK 8.5bDKK 647.9mDKK 171.7m35.3x49.4x13.1x
Tue, 02 Jan 2024DKK 8.8bDKK 647.9mDKK 171.7m37.8x51.2x13.6x
Thu, 30 Nov 2023DKK 7.8bDKK 647.9mDKK 171.7m33x45.4x12x
Sat, 28 Oct 2023DKK 6.2bDKK 647.9mDKK 171.7m25.6x36.2x9.6x
Mon, 25 Sep 2023DKK 7.6bDKK 647.9mDKK 171.7m32.8x44.3x11.7x
Wed, 23 Aug 2023DKK 9.1bDKK 660.6mDKK 184.0m222.9x49.4x13.8x
Fri, 21 Jul 2023DKK 10.0bDKK 660.6mDKK 184.0m207.3x54.2x15.1x
Sun, 18 Jun 2023DKK 10.5bDKK 660.6mDKK 184.0m208.8x56.9x15.9x
Tue, 16 May 2023DKK 9.2bDKK 660.6mDKK 184.0m207.4x50.2x14x
Thu, 13 Apr 2023DKK 6.5bDKK 461.2mDKK 179.7m36.2x36.2x14.1x
Sat, 11 Mar 2023DKK 7.0bDKK 461.2mDKK 179.7m39.1x39.1x15.3x
Mon, 06 Feb 2023DKK 11.3bDKK 428.4mDKK 159.5m70.8x70.8x26.3x
Wed, 04 Jan 2023DKK 12.1bDKK 428.4mDKK 159.5m75.6x75.6x28.2x
Fri, 02 Dec 2022DKK 15.4bDKK 428.4mDKK 159.5m96.5x96.5x35.9x
Sun, 30 Oct 2022DKK 12.5bDKK 428.4mDKK 159.5m78.4x78.4x29.2x
Tue, 27 Sep 2022DKK 10.7bDKK 428.4mDKK 159.5m66.8x66.8x24.9x
Thu, 25 Aug 2022DKK 14.4bDKK 358.0mDKK 131.3m109.9x109.9x40.3x
Sat, 23 Jul 2022DKK 14.3bDKK 358.0mDKK 131.3m108.8x108.8x39.9x
Mon, 20 Jun 2022DKK 13.0bDKK 358.0mDKK 131.3m99.1x99.1x36.3x
Wed, 18 May 2022DKK 12.4bDKK 358.0mDKK 131.3m94.2x94.2x34.5x
Fri, 15 Apr 2022DKK 15.7bDKK 358.0mDKK 131.3m119.7x119.7x43.9x
Sun, 13 Mar 2022DKK 13.6bDKK 358.0mDKK 131.3m103.5x103.5x37.9x
Tue, 08 Feb 2022DKK 11.6bDKK 281.1mDKK 88.4m131.8x131.8x41.4x
Price to Earnings Ratio

131.8x


Total Market Cap: DKK 11.6bTotal Earnings: DKK 88.4mTotal Revenue: DKK 281.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Clinical Research and Equipment Industry Price to Earnings3Y Average 97.7x202320242025
Current Industry PE
    There are only 2 companies in the Danish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 31% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Danish Clinical Research and Equipment compare with similar industries?

DK Market-0.75%
Healthcare-1.93%
Life Sciences7.55%
Clinical Research and Equipment7.55%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CHEMM ChemoMetecDKK 560.0012.5%
+DKK 1.1b		54.5%PE71.5x
GUBRA GubraDKK 662.003.4%
+DKK 358.8m		394.0%PS48.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GUBRA

DKK 662.00

Gubra

7D

3.4%

1Y

394.0%

CHEMM

DKK 560.00

ChemoMetec

7D

12.5%

1Y

54.5%